Literature DB >> 1911654

Evaluation of bilirubin as possible protective factor in the prevention of retinopathy of prematurity.

D D Gaton1, J Gold, R Axer-Siegel, E Wielunsky, N Naor, I Nissenkorn.   

Abstract

Retinopathy of prematurity (ROP) appears to be a multifactorial disease, the prevention of which is probably impossible even with the most accurate methods of blood-gas monitoring and oxygen restrictions. The oxidative processes and consequent formation of free radicals are probably influenced by the availability of various antioxidants in the immature retina. Bilirubin, the end product of haem catabolism, has recently been regarded as a potential physiological antioxidant. In order to test the suggestion as to the possible effect of bilirubin in reducing the incidence of ROP a retrospective study was undertaken of the medical records of 151 neonates born between 1984 to 1988 who weighed less than 1500 g. Of these, 78 had various degrees of ROP, whereas 73 had no ROP and served as a control group. The daily mean bilirubin values were analysed in accordance with gestational age and birth weight as well as the severity of ROP, and the results were compared with those obtained for the control group. The results showed no correlation between bilirubin levels and severity of ROP in all subgroups of gestational age and birth weight. These findings indicate that there is no apparent protective effect of bilirubin on the development of ROP.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1911654      PMCID: PMC1042467          DOI: 10.1136/bjo.75.9.532

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  11 in total

Review 1.  Retinopathy of prematurity.

Authors:  I Ben Sira; I Nissenkorn; I Kremer
Journal:  Surv Ophthalmol       Date:  1988 Jul-Aug       Impact factor: 6.048

2.  High postmortem levels of hypoxanthine in the vitreous humor of premature babies with respiratory distress syndrome.

Authors:  O D Saugstad; T O Rognum
Journal:  Pediatrics       Date:  1988-03       Impact factor: 7.124

3.  Vision loss due to retinopathy of prematurity.

Authors:  D L Phelps
Journal:  Lancet       Date:  1981-03-14       Impact factor: 79.321

4.  Retinopathy of prematurity and bilirubin.

Authors:  E Heyman; A Ohlsson; P Girschek
Journal:  N Engl J Med       Date:  1989-01-26       Impact factor: 91.245

5.  Retinopathy of prematurity: incidence and risk factors.

Authors:  M Shohat; S H Reisner; R Krikler; I Nissenkorn; Y Yassur; I Ben-Sira
Journal:  Pediatrics       Date:  1983-08       Impact factor: 7.124

6.  Bilirubin is an antioxidant of possible physiological importance.

Authors:  R Stocker; Y Yamamoto; A F McDonagh; A N Glazer; B N Ames
Journal:  Science       Date:  1987-02-27       Impact factor: 47.728

7.  Potential role of conjugated bilirubin and copper in the metabolism of lipid peroxides in bile.

Authors:  R Stocker; B N Ames
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

8.  Antioxidant activity of albumin-bound bilirubin.

Authors:  R Stocker; A N Glazer; B N Ames
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

Review 9.  A reexamination of the role of oxygen in retrolental fibroplasia.

Authors:  J F Lucey; B Dangman
Journal:  Pediatrics       Date:  1984-01       Impact factor: 7.124

10.  Vitamin E protects against retinopathy of prematurity through action on spindle cells.

Authors:  F L Kretzer; R S Mehta; A T Johnson; D G Hunter; E S Brown; H M Hittner
Journal:  Nature       Date:  1984 Jun 28-Jul 4       Impact factor: 49.962

View more
  9 in total

1.  An elevated level of copper zinc superoxide dismutase fails to prevent oxygen induced retinopathy in mice.

Authors:  C Klaeger; L de Sa; A J Klaeger; E J Carlson; W V Good; C J Epstein
Journal:  Br J Ophthalmol       Date:  1996-05       Impact factor: 4.638

2.  Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury.

Authors:  S Doré; M Takahashi; C D Ferris; R Zakhary; L D Hester; D Guastella; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

Review 3.  Retinopathy of prematurity: a review of risk factors and their clinical significance.

Authors:  Sang Jin Kim; Alexander D Port; Ryan Swan; J Peter Campbell; R V Paul Chan; Michael F Chiang
Journal:  Surv Ophthalmol       Date:  2018-04-19       Impact factor: 6.048

4.  Possible roles of bilirubin and breast milk in protection against retinopathy of prematurity.

Authors:  Joanna S Kao; Jeffrey D Dawson; Jeffrey C Murray; John M Dagle; Susan K Berends; Susan B Gillen; Edward F Bell
Journal:  Acta Paediatr       Date:  2010-11-05       Impact factor: 2.299

5.  17β-estradiol ameliorates oxygen-induced retinopathy in the early hyperoxic phase.

Authors:  Hongbing Zhang; Xiaodong Wang; Kun Xu; Yao Wang; Yani Wang; Xianning Liu; Xianjiao Zhang; Liang Wang; Xiaogang Li
Journal:  Biochem Biophys Res Commun       Date:  2015-01-22       Impact factor: 3.575

6.  Retinopathy of prematurity and bilirubin--no clinical evidence for a beneficial role of bilirubin as a physiological anti-oxidant.

Authors:  J C Fauchère; F E Meier-Gibbons; F Koerner; E Bossi
Journal:  Eur J Pediatr       Date:  1994-05       Impact factor: 3.183

7.  Potential protective effects of bilirubin following the treatment of neonatal hypoxic-ischemic encephalopathy with hypothermia therapy.

Authors:  Liangyan Zou; Hao Yuan; Qing Liu; Chunmei Lu; Laishuan Wang
Journal:  Biosci Rep       Date:  2019-06-04       Impact factor: 3.840

8.  Incidence and risk factors of retinopathy of prematurity in three neonatal intensive care units in Palestine.

Authors:  Mohammad T Akkawi; Mohammad M Shehadeh; Amjaad N Abu Shams; Doaa M Al-Hardan; Lara J Omar; Omar H Almahmoud; Jamal A S Qaddumi
Journal:  BMC Ophthalmol       Date:  2019-08-20       Impact factor: 2.209

Review 9.  Two Faces of Heme Catabolic Pathway in Newborns: A Potential Role of Bilirubin and Carbon Monoxide in Neonatal Inflammatory Diseases.

Authors:  Wiktoria Osiak; Sławomir Wątroba; Lucyna Kapka-Skrzypczak; Jacek Kurzepa
Journal:  Oxid Med Cell Longev       Date:  2020-08-18       Impact factor: 6.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.